{
    "code": "02004177",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02004177",
    "time": "2022-04-15 03:55:50",
    "許可證字號": "衛署藥輸字第004177號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/04\/09",
    "發證\/登錄日期": "87\/02\/18",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00200417700",
    "中文品名": "&quot;協和&quot; 鹽酸組織氨酸",
    "英文品名": "L-HISTIDINE MONOHYDROCHLORIDE &quot;KYOWA&quot;",
    "適應症": "氨基酸補給劑",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "HISTIDINE L- HCL (EQ TO L-HISTIDINE HYDROCHLORIDE)",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "1203701100  裕元興業股份有限公司",
    "申請商地址": "台北市松江路１２９號９樓",
    "主製造廠": [
        {
            "": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "29332900005 其他之結構中含有一未稠合之咪唑環（不論是否氫化）之化合物Other compounds containing an unfused imidazole ring (whether or not hydrogened) in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4020100912",
            "成分名稱": "HISTIDINE L- HCL (EQ TO L-HISTIDINE HYDROCHLORIDE)",
            "含量描述": "98+",
            "含量": "",
            "單位": "%"
        }
    ]
}